Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments#USA#Somerville#Brenig_Therapeutics#Neurodegenerative_Diseases#Megan_McGill
Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments
Brenig Therapeutics announces the appointment of Dr. Megan McGill as CEO, focusing on advancements in therapies for neurodegenerative diseases driven by innovative discovery platforms.
third-news.com
October 30, 2025 at 12:28 PM
Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments#USA#Somerville#Brenig_Therapeutics#Neurodegenerative_Diseases#Megan_McGill